Marshall ligament radiofrequency ablation electrode, device and its application
By embedding the set position electrode and the radio frequency electrode in the Marshall ligament radio frequency ablation electrode, and combining the cooling treatment of the water injection hose, the problems of inconvenience and positioning difficulties in the prior art are solved, and the accuracy and safety of radio frequency ablation are improved. .
Patent Information
- Application Number
- CN202311089854.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-08-28
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2043-08-28
AI Technical Summary
During the radiofrequency ablation of Marshall ligaments, the prior art requires frequent adjustment of the exposed part length of the front end of the metal guidewire, which is inconvenient to operate and difficult to accurately locate, which easily causes current to burn the inner wall of the blood vessel.
A Marshall ligament radio frequency ablation electrode is designed, including a positioning electrode and a radio frequency electrode embedded at the front end of the metal guidewire. It is positioned in real time by electrocardiogram positioning method and is cooled by using a water injection hose to avoid the need for silicone hose adjustment.
Real-time positioning and radiofrequency ablation during the intervention process are achieved, the operation process is simplified, the risk of current burning is reduced, and the accuracy and safety of ablation are improved.
Smart Images

Figure CN117379167B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of devices for transmitting non-mechanical energy into a human body, and in particular to a Marshall ligament radiofrequency ablation electrode, a device and applications thereof. Background Art
[0002] Atrial fibrillation is the most common rapid arrhythmia in clinical practice. Epidemiological surveys show that the incidence rate increases with age. Currently, ablation has become the first-line treatment for some patients with paroxysmal atrial fibrillation.
[0003] The Marshall ligament is a relic of the left cardinal vein degeneration during the embryonic period. It is not only an epicardial channel connecting the coronary sinus and the left atrium, but also contains conduction muscle bundles, autonomic nerve fibers, etc. It plays an important role in the triggering and maintenance of atrial arrhythmias such as atrial fibrillation and atrial flutter. Radiofrequency ablation of the Marshall ligament can effectively control the triggering of atrial fibrillation and atrial flutter.
[0004] At present, radiofrequency ablation of Marshall's ligament is performed by inserting a metal guide wire through the coronary sinus into the Marshall's ligament for radiofrequency ablation. The operation steps are to first use electrocardiographic positioning technology to locate the front end of the metal guide wire to ensure that the front end of the metal guide wire is at the location of the Marshall's ligament, and then use the metal guide wire to apply a certain power and a certain duration of current to the Marshall's ligament for radiofrequency ablation.
[0005] During the above operation, when using electrical positioning technology for positioning, the conductive part of the front end of the metal guide wire is required to be as short as possible to reduce the contact area between the front end of the metal guide wire and the heart, thereby accurately locating the position of the front end of the metal guide wire. When performing radiofrequency ablation, the conductive part of the front end of the metal guide wire is required to have a certain length to increase the contact area for ablation.
[0006] During ablation, the rest of the metal guide wire except the front and rear ends needs to be insulated from the inner wall of the blood vessel, otherwise the current will burn the inner wall of the blood vessel along the metal guide wire. Since there is currently no metal guide wire suitable for radiofrequency ablation, a commonly used method in actual operation is to set a hollow silicone hose on the outside of the metal guide wire to achieve insulation through the silicone hose. However, during electrical positioning, it is necessary to push the silicone hose into the blood vessel for a certain distance to shorten the length of the exposed part of the front end of the metal guide wire, which is convenient for electrical positioning. During radiofrequency ablation, it is necessary to pull the silicone hose out of the blood vessel for a certain distance to lengthen the length of the exposed part of the front end of the metal guide wire to increase the contact area during ablation. During clinical operation, the length of the silicone hose can only be controlled by the doctor's experience and feel, which is very inconvenient to operate. Summary of the invention
[0007] In view of the shortcomings of the prior art, the present invention proposes a Marshall ligament radiofrequency ablation electrode, device and application thereof. It is not necessary to use a silicone hose to adjust the length of the exposed front end of the metal guide wire, so that doctors can operate. The specific technical solution is as follows:
[0008] In a first aspect, a Marshall ligament radiofrequency ablation electrode is provided, comprising:
[0009] A metal guide wire with an outer surface coated with an insulating layer;
[0010] The radio frequency electrode and the positioning electrode are embedded in the front end of the metal guide wire and are sequentially spaced along the length direction of the metal guide wire.
[0011] In combination with the first aspect, in a first implementation manner of the first aspect, the interval length between the positioning electrode and the radio frequency electrode is 2 mm.
[0012] In combination with the first aspect, in a second implementation manner of the first aspect, the length of the positioning electrode is 2 mm.
[0013] In combination with the first aspect, in a third implementation manner of the first aspect, the length of the radio frequency electrode is 20 mm.
[0014] In combination with the first aspect, in a fourth implementable manner of the first aspect, a water injection hose is further included, and the metal guide wire is attached to the outer wall surface of the water injection hose.
[0015] In combination with the fourth implementable manner of the first aspect, in a fifth implementable manner of the first aspect, the front end of the water injection hose is located behind the radio frequency electrode and close to the position of the radio frequency electrode.
[0016] In combination with the fifth implementable manner of the first aspect, in a sixth implementable manner of the first aspect, the front end of the water injection hose is 24 mm away from the front end of the metal guide wire.
[0017] In combination with the fourth implementable manner of the first aspect, in a seventh implementable manner of the first aspect, the water injection hose is made of silicone.
[0018] In a second aspect, a Marshall ligament radiofrequency ablation device is provided, comprising:
[0019] The Marshall ligament radiofrequency ablation electrode as described in the first aspect or any one of the first to seventh possible implementations of the first aspect;
[0020] An ECG positioning device is connected to the radio frequency electrode and the positioning electrode signals, and is configured to locate the position of the positioning electrode by using the radio frequency electrode and the positioning electrode and adopting an ECG positioning method;
[0021] The radiofrequency ablation device is electrically connected to the radiofrequency electrode and is configured to output radiofrequency current.
[0022] In a third aspect, an application of a Marshall ligament radiofrequency ablation electrode is provided, wherein the Marshall ligament radiofrequency ablation electrode as described in the first aspect or any one of the first to seventh possible implementations of the first aspect is applied to a radiofrequency ablation system for Marshall ligament.
[0023] Beneficial effects: The Marshall ligament radiofrequency ablation electrode, device and application thereof of the present invention can locate the contact position between the front end of the metal guide wire and the heart in real time during the intervention process through the provided positioning electrode. When the front end of the metal guide wire reaches the Marshall ligament, the metal guide wire can be pushed inward for a certain distance, so that the radiofrequency electrode behind the positioning electrode moves to the Marshall ligament for radiofrequency ablation. In this way, radiofrequency ablation can be achieved without using a silicone hose to adjust the length of the exposed part of the front end of the metal guide wire, so that the doctor can operate. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] In order to more clearly illustrate the specific implementation of the present invention, the following will briefly introduce the drawings required for use in the specific implementation. In all the drawings, each element or part is not necessarily drawn according to the actual scale.
[0025] Figure 1 A schematic diagram of the structure of a Marshall ligament radiofrequency ablation electrode provided by an embodiment of the present invention;
[0026] Figure 2 A schematic diagram of the structure of a Marshall ligament radiofrequency ablation electrode provided by an embodiment of the present invention;
[0027] Reference numerals:
[0028] 1-metal guide wire, 2-radio frequency electrode, 3-positioning electrode, 4-water injection hose. DETAILED DESCRIPTION
[0029] The following embodiments of the technical solution of the present invention are described in detail in conjunction with the accompanying drawings. The following embodiments are only used to more clearly illustrate the technical solution of the present invention, and are therefore only used as examples, and cannot be used to limit the protection scope of the present invention.
[0030] like Figure 1 The structure diagram of the Marshall ligament radiofrequency ablation electrode shown in FIG. 1 includes:
[0031] A metal guide wire 1, the outer surface of which is coated with an insulating layer;
[0032] The radio frequency electrode 2 and the positioning electrode 3 are embedded in the front end of the metal guide wire 1 and are sequentially spaced apart along the length direction of the metal guide wire 1 .
[0033] Specifically, the ablation electrode includes a metal guide wire 1, a radio frequency electrode 2 and a positioning electrode 3. The positioning electrode 3 and the radio frequency electrode 2 are both arranged at the front end of the metal guide wire 1 and are in direct contact with the metal guide wire 1. The positioning electrode 3 is arranged at the front end of the metal guide wire 1, and the radio frequency electrode 2 is arranged at a position close to the positioning electrode 3 and is spaced a certain distance from the positioning electrode 3. The outer surface of the metal guide wire 1 between the positioning electrode 3 and the radio frequency electrode 2 and between the radio frequency electrode 2 and the rear end of the metal guide wire 1 is coated with an insulating layer to prevent the metal guide wire 1 from burning the blood vessel during ablation.
[0034] During the intervention of the metal guide wire 1, a signal clamp can be used to connect the metal guide wire 1 to the ECG monitor signal. The ECG monitor can monitor the characteristic changes in the electrocardiogram during the intervention to determine the contact position between the front end of the metal guide wire 1 and the heart, so as to push the front end of the metal guide wire 1 to the Marshall ligament.
[0035] After confirming that the front end of the metal guide wire 1 is pushed to the Marshall ligament, the metal guide wire 1 can be pushed inward to push the radiofrequency electrode 2 to the Marshall ligament. The pushing distance is the same as the distance between the radiofrequency electrode 2 and the positioning electrode 3. After that, the radiofrequency ablation device can be connected to the metal guide wire 1 using a signal clip, and the radiofrequency ablation device can output radiofrequency current for radiofrequency ablation.
[0036] Before radiofrequency ablation, the metal guide wire 1 and the extracorporeal electrode can be connected to the potentiometer signal, and the potential at the Marshall ligament position before ablation can be detected by the potentiometer. After radiofrequency ablation, the metal guide wire 1 can also be connected to the potentiometer signal, and the potential at the Marshall ligament position after ablation can be detected by the potentiometer. By comparing the potential changes before and after ablation, it can be determined whether the Marshall ligament has been ablated.
[0037] In this embodiment, optionally, the interval length between the positioning electrode 3 and the radio frequency electrode 2 is 2 mm.
[0038] In this embodiment, optionally, the length of the positioning electrode 3 is 2 mm.
[0039] In this embodiment, optionally, the length of the RF electrode 2 is 20 mm.
[0040] In this embodiment, optionally, Figure 2As shown, a water injection hose 4 is also included, and the metal guide wire 1 is attached to the outer wall surface of the water injection hose 4. Specifically, considering the local high temperature generated during radiofrequency ablation, the metal guide wire 1 can be attached to the water injection hose 4, and the water injection hose 4 is made of silicone. When the metal guide wire 1 is inserted, the water injection hose 4 is pushed to the ablation position. When performing radiofrequency ablation, water can be injected into the ablation position through the water injection hose 4 to cool the ablation position.
[0041] In this embodiment, optionally, the front end of the water injection hose 4 is located behind the RF electrode 2 and close to the RF electrode 2 to prevent the RF electrode 2 and the positioning electrode 3 from being blocked by the water injection hose 4, so that the positioning electrode 3 and the RF electrode 2 are always in an exposed state.
[0042] In this embodiment, optionally, the front end of the water injection hose 4 is 24 mm away from the front end of the metal guide wire 1 .
[0043] A Marshall ligament radiofrequency ablation device, comprising:
[0044] The above-mentioned ligament of Marshall radiofrequency ablation electrode;
[0045] An electrocardiographic positioning device is connected to the radio frequency electrode 2 and the positioning electrode 3 by signals, and is configured to locate the position of the positioning electrode 3 by using the radio frequency electrode 2 and the positioning electrode 3 and adopting an electrocardiographic positioning method;
[0046] The radiofrequency ablation device is electrically connected to the radiofrequency electrode 2 and is configured to output radiofrequency current.
[0047] Specifically, the radiofrequency ablation device is composed of the above-mentioned ablation electrode, ECG positioning device and radiofrequency ablation device. Among them, the ECG positioning device can be an ECG monitor. When the ablation electrode is implanted, the positioning electrode 3 can be connected to the ECG monitor signal, and the characteristic changes of the ECG during the implantation process can be observed by the ECG monitor to locate the contact position of the positioning electrode 3 with the heart.
[0048] After the electrocardiogram monitor determines that the positioning electrode 3 is pushed to the Marshall ligament, the metal guide wire 1 can be pushed forward 2 mm to push the radiofrequency electrode 2 to the Marshall ligament. After that, the radiofrequency electrode 2 can be connected to the radiofrequency ablation device signal. The radiofrequency ablation device can be an existing radiofrequency therapeutic device, and the radiofrequency therapeutic device can transmit radiofrequency current to the radiofrequency electrode 2 to perform radiofrequency ablation on the Marshall ligament.
[0049] An application of a Marshall ligament radiofrequency ablation electrode, wherein the Marshall ligament radiofrequency ablation electrode is applied to a Marshall ligament radiofrequency ablation system.
[0050] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein by equivalents. These modifications or replacements do not make the essence of the corresponding technical solutions deviate from the scope of the technical solutions of the embodiments of the present invention, and they should all be included in the scope of the claims and specification of the present invention.
Claims
1. A Marshall ligament radiofrequency ablation device, characterized in that: include: Marshall ligament radiofrequency ablation electrode, including: A metal guide wire with an outer surface coated with an insulating layer; The radio frequency electrode and the positioning electrode are embedded in the front end of the metal guide wire, and the positioning electrode is set at the front end of the metal guide wire. The radio frequency electrode is set close to the positioning electrode and is separated from the positioning electrode by a certain distance. The positioning electrode and the radio frequency electrode are in direct contact with the metal guide wire; a radiofrequency ablation device, electrically connected to the radiofrequency electrode via a metal guidewire and configured to output radiofrequency current; An electrocardiographic positioning device is connected to the radiofrequency electrode and the positioning electrode signal through a metal guide wire, and is configured to locate the position of the positioning electrode using an electrocardiographic positioning method through the radiofrequency electrode and the positioning electrode; The contact position between the front end of the metal guide wire and the heart is determined by monitoring the characteristic changes in the electrocardiogram during the interventional process through the ECG positioning device, so as to push the front end of the metal guide wire to the Marshall ligament. After confirming that the front end of the metal guide wire is pushed to the Marshall ligament, the metal guide wire is continued to be pushed inward to push the radiofrequency electrode to the Marshall ligament. The pushing distance is the same as the distance between the radiofrequency electrode and the positioning electrode. After that, the radiofrequency ablation device is connected to the metal guide wire.
2. The Marshall ligament radiofrequency ablation device according to claim 1, characterized in that: The spacing between the positioning electrode and the radio frequency electrode is 2 mm.
3. The Marshall ligament radiofrequency ablation device according to claim 1, characterized in that: The length of the positioning electrode is 2 mm.
4. The Marshall ligament radiofrequency ablation device according to claim 1, characterized in that: The length of the radio frequency electrode is 20 mm.
5. The Marshall ligament radiofrequency ablation device according to claim 1, characterized in that: It also includes a water injection hose, and the metal guide wire is attached to the outer wall surface of the water injection hose.
6. The Marshall ligament radiofrequency ablation device according to claim 5, characterized in that: The front end of the water injection hose is located behind the radio frequency electrode and close to the position of the radio frequency electrode.
7. The Marshall ligament radiofrequency ablation device according to claim 6, characterized in that: The front end of the water injection hose is 24 mm away from the front end of the metal guide wire.
8. The Marshall ligament radiofrequency ablation device according to claim 5, characterized in that: The water injection hose is made of silicone.
